全文获取类型
收费全文 | 4061篇 |
免费 | 254篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 170篇 |
妇产科学 | 115篇 |
基础医学 | 694篇 |
口腔科学 | 132篇 |
临床医学 | 327篇 |
内科学 | 671篇 |
皮肤病学 | 111篇 |
神经病学 | 255篇 |
特种医学 | 449篇 |
外科学 | 427篇 |
综合类 | 49篇 |
预防医学 | 220篇 |
眼科学 | 59篇 |
药学 | 275篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 327篇 |
出版年
2021年 | 59篇 |
2020年 | 45篇 |
2019年 | 39篇 |
2018年 | 64篇 |
2017年 | 39篇 |
2016年 | 66篇 |
2015年 | 73篇 |
2014年 | 90篇 |
2013年 | 141篇 |
2012年 | 148篇 |
2011年 | 157篇 |
2010年 | 149篇 |
2009年 | 149篇 |
2008年 | 174篇 |
2007年 | 178篇 |
2006年 | 148篇 |
2005年 | 139篇 |
2004年 | 131篇 |
2003年 | 160篇 |
2002年 | 127篇 |
2001年 | 106篇 |
2000年 | 79篇 |
1999年 | 119篇 |
1998年 | 119篇 |
1997年 | 108篇 |
1996年 | 83篇 |
1995年 | 81篇 |
1994年 | 59篇 |
1993年 | 67篇 |
1992年 | 84篇 |
1991年 | 66篇 |
1990年 | 65篇 |
1989年 | 93篇 |
1988年 | 63篇 |
1987年 | 57篇 |
1986年 | 50篇 |
1985年 | 63篇 |
1984年 | 38篇 |
1983年 | 32篇 |
1982年 | 37篇 |
1981年 | 23篇 |
1980年 | 27篇 |
1979年 | 20篇 |
1978年 | 38篇 |
1977年 | 32篇 |
1976年 | 31篇 |
1975年 | 23篇 |
1974年 | 20篇 |
1972年 | 31篇 |
1971年 | 27篇 |
排序方式: 共有4343条查询结果,搜索用时 15 毫秒
101.
102.
Javier Arístegui Vytautas Usonis Hoosen Coovadia Stella Riedemann Khin Maung Win Salvacion Gatchalian Hans L Bock 《International journal of infectious diseases》2003,7(2):143-151
BACKGROUND: Vaccines are important weapons in the fight against infectious diseases. The World Health Organization (WHO) Expanded Program on Immunization (EPI) has been extended to include recommendations for hepatitis B and Haemophilus influenzae type b (Hib) vaccinations. The WHO has recommended that combined vaccines be used where possible, to reduce the logistic costs of vaccine delivery. This paper reviews the efficacy, safety and cost-effectiveness of Tritanrix-HB/Hib, the only commercially available combined diphtheria, tetanus, whole cell pertussis, hepatitis B and conjugated Hib vaccine. METHODS: The immunogenicity and reactogenicity results of five published clinical trials involving Tritanrix-HB/Hib in a variety of immunization schedules and countries were reviewed. Based on these data and cost-effectiveness studies, an assessment of its suitability for use in national immunization programs was made. RESULTS: Tritanrix-HB/Hib has shown excellent immunogenicity in clinical trials using a variety of schedules, with no reduced immunogenicity observed for any of the components of the combined vaccine. It has similar reactogenicity to DTPw vaccines alone. Pharmacoeconomic analyses have shown combined DTP-HB/Hib vaccines to be cost-effective compared to separate vaccines. CONCLUSIONS: Replacement of DTPw vaccination by Tritanrix-HB/Hib can be done without modifying the existing national immunization programs. This should facilitate widespread coverage of hepatitis B and Hib vaccinations and their rapid incorporation into the EPI. 相似文献
103.
Saskia PJ Verkleij Pim AJ Luijsterburg Sten P Willemsen Bart W Koes Arthur M Bohnen Sita MA Bierma-Zeinstra 《The British journal of general practice》2015,65(637):e530-e537
Background
The effectiveness of diclofenac versus paracetamol in primary care patients with pain caused by knee osteoarthritis is unclear.Aim
To assess the effectiveness of diclofenac compared with paracetamol over a period of 2, 4, and 12 weeks in patients with knee osteoarthritis.Design and setting
Randomised controlled trial in general practice.Method
There were 104 patients included in the study, they were aged ≥45 years consulting their GP with knee pain caused by knee osteoarthritis. Patients were randomly allocated to diclofenac (n = 52) or paracetamol (n = 52) for at least 2 weeks. Primary outcomes were daily knee pain severity, and knee pain and function measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS).Results
Over a period of 2- and 4-weeks follow-up, no significant difference in daily knee pain was found between the patient groups: estimated differences of 0.5 (95% CI = −0.2 to 1.3) and −0.2 (95% CI = −1.0 to 0.7), respectively. Over the 12-weeks follow-up, no significant differences were found between both groups for KOOS pain: estimated difference of −2.8 (95% CI = −10.7 to 5.1) and KOOS function of −2.7 (−10.6 to 5.0).Conclusion
Over a period of 2- and 4-weeks follow-up no significant difference in daily measured knee pain severity was found between primary care patients with knee osteoarthritis taking paracetamol or diclofenac. Also, over a period of 12-weeks follow-up no significant differences were found regarding KOOS pain and KOOS function between both groups. Patients more frequently reported minor adverse events after taking diclofenac (64%) than paracetamol (46%). 相似文献104.
Hu L Lytras A Bock ME Yuen CK Dodd JG Cattini PA 《Molecular and cellular endocrinology》1999,157(1-2):131-142
Diabetes is a common complication encountered during pregnancy. Earlier studies indicated that diabetic placentas bear morphological alterations consistent with modified placental differentiation, including alterations in the villous cellular content, structure, and total surface. Limited data associating the diabetic status with the expression of terminal placental differentiation markers are available. The human growth hormone/chorionic somatomammotropin (hGH/CS) family consists of five genes, one of which (GH-N) is expressed efficiently in pituitary while the other four (CS-A, B, L, and hGH-V) are expressed in placenta and represent ultimate placental differentiation markers. We developed and applied a sensitive RT-PCR method coupled with diagnostic restriction digestion to determine the relative levels of the hGH/CS family in normal pregnancies and examine whether their mRNA expression pattern is altered in pregnancies complicated by diabetes. We show that relative hCS-L content changes during placental development. Specifically, normal term placentas express higher relative levels of hCS-L, lower relative hGH-V levels and a 70-fold lower hGH-V/CS-L mRNA ratio compared to early placentas. Also, many term placentas from diabetic pregnancies express lower relative levels of hCS-L mRNA and a much higher hGH-V/CS-L mRNA ratio compared to normal term placenta, resembling more an early placenta pattern of expression. Thus, our study suggests that the expression of terminal placental differentiation markers, such as the hGH/CS genes, is altered in term placentas from these diabetics reflecting either impaired placental differentiation or post-differentiation impairment of normal placental function. 相似文献
105.
Styles LA; Schalkwijk CG; Aarsman AJ; Vichinsky EP; Lubin BH; Kuypers FA 《Blood》1996,87(6):2573-2578
Acute chest syndrome (ACS) is associated with significant morbidity and is the leading cause of death in patients with sickle cell disease (SCD). Recent reports suggest that bone marrow fat embolism can be detected in many cases of severe ACS. Secretory phospholipase A2 (sPLA2) is an important inflammatory mediator and liberates free fatty acids, which are felt to be responsible for the acute lung injury of the fat embolism syndrome. We measured SPLA2 levels in 35 SCD patients during 20 admissions for ACS, 10 admissions for vaso-occlusive crisis, and during 12 clinic visits when patients were at the steady state. Eleven non-SCD patients with pneumonia were also evaluated. To determine if there was a relationship between sPLA2 and the severity of ACS we correlated SPLA2 levels with the clinical course of the patient. In comparison with normal controls (mean = 3.1 +/- 1.1 ng/mL), the non- SCD patients with pneumonia (mean = 68.6 +/- 82.9 ng/mL) and all three SCD patient groups had an elevation of SPLA2 (steady state mean = 10.0 +/- 8.4 ng/mL; vaso-occlusive crisis mean = 23.7 +/- 40.5 ng/mL; ACS mean = 336 +/- 209 ng/mL). In patients with ACS sPLA2 levels were 100- fold greater than normal control values, 35 times greater than values in SCD patients at baseline, and five times greater than non-SCD patients with pneumonia. The degree of SPLA2 elevation in ACS correlated with three different measures of clinical severity and, in patients followed sequentially, the rise in SPLA2 coincided with the onset of ACS. The dramatic elevation of SPLA2 in patients with ACS but not in patients with vaso-occlusive crisis or non-SCD patients with pneumonia and the correlation between levels of SPLA2 and clinical severity suggest a role for SPLA2 in the diagnosis and, perhaps, in the pathophysiology of patients with ACS. 相似文献
106.
107.
Structured Clinical Documentation to Improve Quality and Support Practice‐Based Research in Headache 下载免费PDF全文
Steven Meyers MD Kelly Claire Simon ScD Stuart Bergman‐Bock MD Franco Campanella DO Revital Marcus MD Angela Mark MD Thomas Freedom MD Susan Rubin MD Irene Semenov DO Rebekah Lai BS Laura Hillman BBA Samuel Tideman MS Anna Pham BS Roberta Frigerio MD Demetrius M. Maraganore MD 《Headache》2018,58(8):1211-1218
108.
Scheding S Meister B Bühring HJ Baum CM Mc Kearn JP Bock T Kanz L Brugger W 《Experimental hematology》2000,28(4):460-470
OBJECTIVE: Neutropenia following high-dose chemotherapy and peripheral blood progenitor cell (PBPC) transplantation might be abrogated by an additional transplantation of ex vivo generated granulopoietic postprogenitor cells (GPPC). Therefore, the ex vivo expansion of CD34(+) PBPC was systematically studied aiming for optimum GPPC production. MATERIALS AND METHODS: CD34(+) PBPC were cultured in serum-free medium comparing different (n = 32) combinations of stem cell factor (S), interleukin 1 (1), interleukin 3 (IL-3) (3), interleukin-6 (6), erythropoietin (E), granulocyte colony-stimulating factor (G), granulate-macrophage colony-stimulating factor (GM), daniplestim (D, a novel IL-3 receptor agonist), and Flt3 ligand (FL) under various culture conditions. Ex vivo generated cells were assessed by flow cytometry, morphology, and progenitor cell assays. RESULTS: Addition of G +/- GM but not GM alone to cultures stimulated with S163E effectively induced the generation of GPPC. GPPC production was maximum after 12 to 14 days. Best expansion rates were observed when cells were cultured at 1.5x10(4)/mL in 21% O(2). Modifications of culture conditions were either less or equally effective (i.e., modification of starting cell concentrations, low oxygen, addition of serum albumin or autologous plasma, repetitive feeding). Comparison of different cytokine combinations revealed that the optimum GPPC expansion cocktail consisted of S6GD+FL (day 12: 130-fold cellular expansion, 32% myeloblasts/promyelocytes, 49.4% myelocytes/metamyelocytes, 12.4% bands/segmented), which furthermore expanded CD34(+) cells (3.4-fold) and clonogenic progenitors (13.4-fold). CONCLUSION: Using the S6DG+FL expansion cocktail, GPPC could be effectively produced ex vivo starting from positively selected CD34 PBPC, possibly enabling amelioration or even abrogation of posttransplant neutropenia. 相似文献
109.
Bodil Gessler David Bock Hans-Christian Pommergaard Jakob Burcharth Jacob Rosenberg Eva Angenete 《International journal of colorectal disease》2016,31(4):895-902
Purpose
The aim of this was to assess potential risk factors for anastomotic dehiscence in colon cancer surgery in a national cohort.Methods
All patients, who had undergone a resection of a large bowel segment with an anastomosis between 2008 and 2011, were identified in the Swedish Colon Cancer Registry. Patient factors, socioeconomic factors, surgical factors, and medication and hospital data were combined to evaluate risk factors for anastomotic dehiscence.Results
The prevalence of anastomotic dehiscence was 4.3 % (497/11 565). Male sex, ASA classification III–IV, prescribed medications, bleeding more than 300 mL, and uncommon colorectal resections were associated with a higher risk of anastomotic dehiscence. Hospital stay was increased with 14.5 days, and 30-day mortality as well as long-term mortality was higher in the anastomotic dehiscence group.Conclusions
There are several factors that are possible to know preoperatively or during surgery that can indicate whether an anastomosis is an appropriate option. Anastomotic dehiscence increases hospital stay and long-term mortality.110.
17 cases of malacoplakia in association with an adenocarcinoma of the colon or rectum are known. In this report we describe a new case of this rare combination. An 83-year-old comatose female patient was admitted in an emergency situation because of an incipient ileus. A carcinoma had been known for months, but the patient had previously rejected any diagnostic or therapeutic measures. A tumor (6 cm in diameter) in the upper rectum was removed. This tumor had caused an obstruction of the lumen and reached the serosa. Histologically, an adenocarcinoma with suppurations in the stroma was staged pT3, G2, pN0 (clinically pT4 because of the perforated colonic wall). PAS- and von-Kossa-positive Michaelis-Gutmann-bodies were found in macrophages. Ultrastructurally, they turned out to be circular shifted early stage calcifications. Any malacoplakia-like lesion in suspicious areas of the colonic wall should be followed up by further diagnostic measures, since it may indicate the presence of an adenocarcinoma. 相似文献